Yale Medicine School: Participant-Centric Trial Will Test If Antiviral Paxlovid Can Help With Long COVID
April 04, 2023
April 04, 2023
NEW HAVEN, Connecticut, April 4 (TNSres) -- Yale School of Medicine issued the following news:
Millions of people worldwide are suffering from often debilitating symptoms of long COVID that can persist weeks, months, or even years following an acute infection. But researchers are still in the dark on the mechanisms underlying and how to treat the mysterious post-viral syndrome. A new clinical trial using the oral antiviral Paxlovid will provide urgently needed insights for COVID lon . . .
Millions of people worldwide are suffering from often debilitating symptoms of long COVID that can persist weeks, months, or even years following an acute infection. But researchers are still in the dark on the mechanisms underlying and how to treat the mysterious post-viral syndrome. A new clinical trial using the oral antiviral Paxlovid will provide urgently needed insights for COVID lon . . .